Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

Perflubron - Oxygent

Drug Profile

Perflubron - Oxygent

Alternative Names: AF 0144; Oxygent

Latest Information Update: 07 Dec 2015

Price : $50 *
* Final gross price and currency may vary according to local VAT and billing address.
* Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase. A link to download a PDF version of the drug profile will be included in your email receipt. Adis is an information provider. We do not sell or distribute the pharmaceutical compounds written about in this database.

At a glance

  • Originator Alliance Pharmaceutical Corporation
  • Class Fluorocarbons; Small molecules
  • Mechanism of Action Oxygen carriers
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

  • New Molecular Entity No

Highest Development Phases

  • Discontinued Hypoxia

Most Recent Events

  • 21 Nov 2007 Discontinued - Phase-II for Acute hypoxia in France (IV)
  • 08 Feb 2007 Phase-II clinical trials in the prevention of post-operative ileus resulting from hypoxia in France(IV)
  • 20 Dec 2006 French Competent Authority has granted approval to initiate a phase II trial
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top